Organization Profile

You just read:

Transition Therapeutics Announces Results from Phase 1 AME & Renal Clearance Clinical Studies of Neuropsychiatric Drug Candidate ELND005

News provided by

Transition Therapeutics Inc.

Mar 26, 2015, 06:01 ET